Has anyone heard of this? The article further states, "Swiss drug developer Roche said Friday six cases of patients with heart failure symptoms prompted a halt to enrollment in a National Cancer Institute sponsored study of its blockbuster drug Avastin."
Full article: http://seattletimes.nwsource.com/html/businesstechnology/2009944446_apusroc heavastinstudy.html
I just had my first Avastin treatment last week -- not as part of a study. I'm triple-negative with 1 met to the right 8th rib, one met to the upper lobe of the left lung, and 2 small brain mets. I'm an oddball case, so many doctors in the area coferred about my treatment and came up with Abraxane/Avastin/Zometa.
I don't see my doctor until next week, but I'll ask him about this at that time. Meanwhile, any opinions or thoughts?




Add to the discussion